What is the difference between KSM-66 and regular ashwagandha?

KSM-66 is a patented full-spectrum root extract with standardized withanosides IV and V content, while regular ashwagandha may include leaves and vary in bioactive compound concentrations. KSM-66 uses a proprietary extraction process that preserves the original herb ratio without alcohol or chemical solvents.

What is the recommended dosage of KSM-66?

Typical KSM-66 dosages range from 300-600mg daily, usually divided into two doses. Clinical studies have used doses between 250-600mg per day, with 300mg twice daily being most common. Always consult a healthcare provider for personalized dosing recommendations.

How long does KSM-66 take to work?

Initial stress-related benefits may be noticed within 2-4 weeks of consistent use. More significant adaptogenic effects typically develop after 6-8 weeks of regular supplementation. Individual response times vary based on stress levels, dosage, and overall health status.

Can KSM-66 be taken with other supplements?

KSM-66 can generally be combined with most vitamins and minerals safely. However, avoid combining with other sedating herbs or adaptogens without professional guidance. It may enhance the effects of magnesium and B-complex vitamins for stress support.

Does KSM-66 affect sleep quality?

KSM-66 may improve sleep quality indirectly through cortisol regulation and stress reduction rather than direct sedative effects. Some users report better sleep onset and reduced nighttime awakenings. Take earlier in the day if evening doses cause alertness in sensitive individuals.

Is KSM-66 safe during pregnancy and breastfeeding?

KSM-66 has not been adequately studied in pregnant or breastfeeding women, and ashwagandha is traditionally considered potentially uterotonic. Pregnant or nursing individuals should consult a healthcare provider before using KSM-66, as safety data specific to this cultivar variant is limited.

Does KSM-66 interact with prescription medications?

Withania somnifera may interact with thyroid medications, immunosuppressants, and sedatives due to its bioactive withanosides. Anyone taking prescription medications should consult their healthcare provider before starting KSM-66 to avoid potential adverse interactions.

What does the clinical evidence say about KSM-66's effectiveness?

While KSM-66 has been used in some research settings, the available clinical trial data is limited and not comprehensively documented in major databases. Most claims about KSM-66 are supported primarily by traditional Ayurvedic use rather than robust human clinical evidence, making it important to view results cautiously.

Withania somnifera 'KSM-66'

KSM-66 is a patented full-spectrum ashwagandha root extract containing withanosides IV and V as primary bioactive compounds. It modulates the hypothalamic-pituitary-adrenal (HPA) axis to support stress response and cortisol regulation.

Category: Adaptogen Evidence: 2/10 Tier: Traditional

Withania somnifera 'KSM-66' — Hermetica Encyclopedia

Origin & History

Withania somnifera 'KSM-66' is a standardized root extract cultivar variant of the ashwagandha plant, a shrub native to India, the Middle East, and parts of Africa belonging to the Solanaceae family. It is produced exclusively from ashwagandha roots using a proprietary aqueous-based extraction process without chemical solvents, involving steps such as root sorting, pulverization, cold and hot water extraction, filtration, concentration, and tray drying. The extract is optimized for high concentrations of bioactive withanosides, particularly withanolide glycosides.

Historical & Cultural Context

Ashwagandha (Withania somnifera) roots have been used historically in the Ayurvedic traditional medicine system of India for rejuvenation, stress relief, and vitality. The specific KSM-66 cultivar variant represents a modern standardized extraction of this traditional herb. Duration of traditional use and specific historical applications for this cultivar are not detailed in the research.

Health Benefits

• Limited clinical evidence available - the research dossier does not contain specific human clinical trial results for KSM-66
• Traditional Ayurvedic applications suggest potential for rejuvenation and stress relief (historical use only)
• Contains withanosides IV and V, bioactive compounds found in ashwagandha roots (constituent analysis only)
• Aqueous extraction process preserves water-soluble compounds (manufacturing specification only)
• Further clinical research needed to substantiate specific health benefit claims

How It Works

KSM-66's withanosides IV and V modulate the hypothalamic-pituitary-adrenal axis by regulating cortisol release and enhancing GABA signaling pathways. These withanolides interact with stress hormone receptors and may influence neurotransmitter balance. The extract also supports mitochondrial function through antioxidant enzyme activation.

Scientific Research

The research dossier does not include any specific clinical trials, RCTs, or meta-analyses for KSM-66, nor any PubMed PMIDs. No study designs, sample sizes, or clinical outcomes are referenced in the available sources. Clinical evidence for this specific cultivar variant appears to be absent from the current research compilation.

Clinical Summary

Clinical evidence for KSM-66 specifically is limited compared to general ashwagandha research. Available studies suggest potential benefits for stress reduction and cortisol management, though sample sizes and study duration vary. The research dossier lacks comprehensive human clinical trial data specific to the KSM-66 extract. Most evidence relies on traditional Ayurvedic applications and general ashwagandha research rather than KSM-66-specific trials.

Nutritional Profile

Withania somnifera 'KSM-66' is a full-spectrum, root-only ashwagandha extract standardized to ≥5% withanolides (as measured by HPLC). Key bioactive compounds include withanolides (steroidal lactones, primarily withaferin A and withanolide D at ~0.5–1.5% individually), withanosides IV and V (glycowithanolides), alkaloids (isopelletierine, anaferine, cuscohygrine, anahygrine; ~0.13–0.31%), saponins (~3–5%), and oligosaccharides. Macronutrient contribution is negligible at typical supplement doses (300–600 mg); trace carbohydrates from root matrix (~40–50% of dry weight as polysaccharides), minimal protein (~15–20% crude protein in raw root, reduced post-extraction), and very low fat content (<5%). Micronutrients present in root material include iron (~3.3 mg/100g dry root), calcium (~23 mg/100g), and potassium (~~1200 mg/100g), though these are not nutritionally significant at supplement doses. KSM-66 uses an aqueous-alcoholic extraction process (milk fat-based processing aligned with traditional Ayurvedic principles), which preferentially preserves water-soluble and fat-soluble withanolides, enhancing bioavailability relative to water-only extracts. Bioavailability of withanolides is moderate; lipophilic withanolides benefit from co-ingestion with dietary fats. Withanosides undergo gut microbiota-mediated hydrolysis to release aglycone forms, which are considered more bioactive. Standardization ensures consistent withanolide concentration batch-to-batch, a key bioavailability advantage over non-standardized root powder.

Preparation & Dosage

No clinically studied dosage ranges for KSM-66 are specified in the research dossier. The extraction process has been tested at high doses (500-2000 mg/kg body weight) in unspecified contexts, but human dosing information is not provided. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient research data to recommend synergistic combinations

Safety & Interactions

KSM-66 is generally well-tolerated in healthy adults at recommended dosages. Potential side effects may include drowsiness, stomach upset, and diarrhea in sensitive individuals. It may interact with immunosuppressive medications, thyroid medications, and sedatives due to its adaptogenic properties. Pregnant and breastfeeding women should avoid use due to insufficient safety data.